4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-057490
President & CEO sold 13,556 shares at $17.97 ($243,601)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-11-18 | Sale | −13,556 | $17.97 | $243,601 | 299,219 | D: show line 1 in the form |
| Open-market sales · 13,556 sh · avg $17.97 · $243,601 | |||||||
Loading xslF345X03/doc4.xml…